SCHEMBL2227207

SCHEMBL2227207

NCc1csc(-c2ccccc2C(N)=O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.47
KDM4E B2RXH2 3/20 0.46
BCAT2 O15382 1/20 0.45
EIF4E P06730 1/20 0.43
ACHE P22303 1/20 0.43
RAB9A P51151 5/20 0.42
PRNP P04156 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 2/20 0.41
GAA P10253 1/20 0.41
CSNK1A1 P48729 1/20 0.40
TYRO3 Q06418 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3180259 0.80 HTR2B (0.50) HTR2BKDM4EBCAT2EIF4EACHE
SCHEMBL3177607 0.78 HTR2B (0.49) HTR2BKDM4EBCAT2EIF4EACHE
SCHEMBL3260631 0.78 CHRM1 (0.52) HTR2BKDM4EBCAT2EIF4EACHE
SCHEMBL2706854 0.78 TGFBR1 (0.51) HTR2BKDM4EBCAT2EIF4EACHE
SCHEMBL5968562 0.76 RAB9A (0.62) KDM4EBCAT2EIF4ERAB9AALDH1A1
SCHEMBL1968034 0.75 HTR2B (0.46) HTR2BBCAT2EIF4EACHERAB9A
SCHEMBL16619009 0.74 ALDH1A1 (0.73) KDM4ERAB9AL3MBTL1ALDH1A1TDP1
SCHEMBL11177459 0.74 HTR2B (0.44) HTR2BBCAT2EIF4EACHERAB9A
SCHEMBL30263367 0.72 CYP19A1 (0.57) KDM4EBCAT2EIF4ERAB9AL3MBTL1
SCHEMBL590109 0.72 KDM4E (0.62) KDM4ERAB9APRNPL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526090-B1 NEW ANTI-MALARIAL AGENTS MEDICINES FOR MALARIA VENTURE MMV (CH) 2015-08-19 EP disclosed
US-9024033-B2 Anti-malarial agents MMV MEDICINES FOR MALARIA VENTURE (CH) 2015-05-05 US disclosed
US-20120295905-A1 NEW ANTI-MALARIAL AGENTS MMV MEDICINES FOR MALARIA VENTURE (CH) 2012-11-22 US disclosed
WO-2011086531-A2 NEW ANTI-MALARIAL AGENTS MMV MEDICINES FOR MALARIA VENTURE (CH) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295905-A1 NEW ANTI-MALARIAL AGENTS QDPR, DHFR, ITPA HTR2B 3106/4885KDM4E 444/4885BCAT2 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.